Shimozaki, K., Fukuda, K., Ooki, A., Nakayama, I., Yoshino, K., Udagawa, S., Fukuoka, S., Osumi, H., Ogura, M., Wakatsuki, T., Takahari, D., Shinozaki, E., Chin, K., Yamaguchi, K. (2025). Safety and efficacy of first-line nivolumab plus chemotherapy for HER2-negative advanced gastric cancer in real-world patients: Updated analysis.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.4_suppl.341